34 daysTime to First Decision

Medical Sciences Forum, Volume 26, Issue 1

IECV 2023 2024 - 5 articles

The 1st International Electronic Conference on Vaccines

Online | 1–15 December 2023

Volume Editors:
François Meurens, University of Montreal, Canada
Fanny Renois, INRAE, France

Cover Story: The 1st International Electronic Conference on Vaccines (IECV 2023), held on 1–15 December 2023, focused on the theme of “RNA Vaccines, Current Challenges and Future Developments”. IECV 2023 provided a platform to examine, explore, and critically engage with issues and advances in the following areas: 1) vaccines to counter anti-microbial resistance; 2) vaccines to eradicate endemic disease—opportunities and challenges; 3) vaccine platforms—advantages and disadvantages; 4) clinical trial design for reactive and preventive vaccination; 5) advances in vaccine formulation and adjuvantisation; 6) clinical view on routinisation of RNA vaccines; etc.

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

Select all

Editorial

1,476 Views

3 Pages

Preface: The 1st International Electronic Conference on Vaccines—RNA Vaccines, Current Challenges and Future Developments

François Meurens and
Fanny Renois

Med. Sci. Forum2024, 26(1), 5;https://doi.org/10.3390/msf2024026005

8 April 2024

The 1st International Electronic Conference on Vaccines: RNA Vaccines, Current Challenges and Future Developments (IECV 2023), was held on 1–15 December 2023 [...]

Full Article

Proceeding Paper

1,083 Views

7 Pages

Impact of COVID-19 on Influenza Virus Vaccination Coverage

Otávio Reis,
Bruno Fernandes,
Luara Santos and
Paula Távora

Med. Sci. Forum2024, 26(1), 4;https://doi.org/10.3390/IECV2023-16529

1 December 2023

Influenza vaccination is pivotal in alleviating healthcare burdens and possibly curbing COVID-19 infections due to symptom overlap. Despite previous suboptimal vaccination rates, the exceptional circumstances of the pandemic may have impacted influen...

Full Article

Proceeding Paper

1,457 Views

7 Pages

Factors Driving the Attitudes and Hesitancy of Albanian Parents toward COVID-19 Vaccination of Children

Irsida Mehmeti and
Emiljan Karma

Med. Sci. Forum2024, 26(1), 3;https://doi.org/10.3390/IECV2023-16531

1 December 2023

In June 2022, the Food and Drug Administration (FDA) authorized the use of Moderna and Pfizer-BioNTech COVID-19 mRNA vaccines for children aged 6 months–4 years in the United States. Vaccine hesitancy is context-, time-, place-, and vaccine-spe...

Full Article

Proceeding Paper

1,083 Views

6 Pages

Perception, Attitude and Intention towards COVID-19 Vaccination

Aarti Chahal,
Rosy Dhall,
Jyotika Kundu and
Nidhi Kataria

Med. Sci. Forum2024, 26(1), 2;https://doi.org/10.3390/IECV2023-16527

1 December 2023

To overcome the situation due to the COVID-19 pandemic, vaccination became essential. So, it is important to understand the overall perception, attitude, and intention of the general population towards vaccination. This study aimed to investigate the...

Full Article

Proceeding Paper

2 Citations

3,859 Views

7 Pages

Challenges Faced by States and the WHO in Efficiently Regulating the Use of mRNA Vaccines

Rabaï Bouderhem

Med. Sci. Forum2024, 26(1), 1;https://doi.org/10.3390/IECV2023-16530

1 December 2023

According to the World Health Organization (WHO), there is no formal regulatory guidance specifically for mRNA-based vaccines. However, the WHO provides information and regulatory considerations regarding key aspects of the manufacture and quality co...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Med. Sci. Forum - ISSN 2673-9992

Imprint

Download Flyer